Literature DB >> 8488714

Absence of protective immunity against diphtheria in a large proportion of young adults.

R Rappuoli1, A Podda, F Giovannoni, L Nencioni, M Peragallo, P Francolini.   

Abstract

The schedule of vaccination recommended worldwide for diphtheria, tetanus and other diseases, provides good immunity during childhood. However, little attention has been paid to effective immunity in adults. We have collected sera from 334 Italian Army recruits and tested them for the presence of protective immunity against diphtheria and tetanus. In vivo neutralization assays were performed on rabbits and mice and values below 1/100 IU ml-1 were considered negative. Of the recruits, 22.9% were negative for diphtheria, while only 5.3% had no protective immunity against tetanus. This finding shows that a large proportion of Italian young adults are susceptible to diphtheria, and this could be dangerous if they travel to sites where this disease is still endemic, or if they come into contact with people coming from such areas. A booster vaccination of young adults against diphtheria should become common practice to avoid this risk. To reduce the side effects which are often associated with diphtheria vaccination in adults, we have developed a vaccine which contains a highly purified, non-toxic mutant of diphtheria toxin. This vaccine is combined with tetanus toxoid and can be routinely used as a booster in adults.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8488714     DOI: 10.1016/0264-410x(93)90235-p

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Serological survey on the immunity to diphtheria of the northern Greek population.

Authors:  E Souliou; V Kyriazopoulou; E Diza; M Hatzistylianou; F Frantzidou
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  Diphtheria antitoxin levels in the 14-30-year age group in Italy.

Authors:  I Mastroeni; A M Patti; A L Santi; N Vescia; S Bocchini; S Bagnod; C Ciapetti; G M Fara
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

3.  Cutaneous and pharyngeal diphtheria imported from the Indian subcontinent.

Authors:  P E Hart; P Y Lee; D C Macallan; M H Wansbrough-Jones
Journal:  Postgrad Med J       Date:  1996-10       Impact factor: 2.401

4.  Development of a direct PCR assay for detection of the diphtheria toxin gene.

Authors:  H Nakao; T Popovic
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Diphtheria revisited.

Authors:  M J Martin
Journal:  Br J Gen Pract       Date:  1995-08       Impact factor: 5.386

6.  An imported fatal case of diphtheria in Italy.

Authors:  C von Hunolstein; A Efstratiou; R La Valle; G Gentili; S Pestalozza; M T Mascellino; R Rappuoli; G Orefici; A Cassone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

7.  Immunity to diphtheria in Izmir, Turkey.

Authors:  A Egemen; Z Kurugöl; S Akşit; T Ozacar; P Keskinoğlu; I Afşar
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

8.  Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.

Authors:  M Singh; X M Li; H Wang; J P McGee; T Zamb; W Koff; C Y Wang; D T O'Hagan
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

Review 9.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

10.  The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV).

Authors:  P Laroche; M Barrand; S C Wood; K Van Hasbrouck; J Lang; E Harzer; L Hessel
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.